New mRNA Injection for Respiratory Syncytial Virus

The pharmaceutical industry, specifically Moderna, is currently setting its own sights on an mRNA injection for the respiratory syncytial virus, which is also known as RSV.

This decision was made after the pharmaceutical industry witnessed the success, better known as “dollar signs”, of the rollout of a Wuhan “vaccine.”

It has been reported that the clinical trial company Javara is collaborating with the Privia Group of healthcare professionals on behalf of Moderna in order to recruit people for clinical trials including the new mRNA jab.

Participants from Georgia, Maryland, and Tex will be turning up their sleeves in preparation for the experimental shot, which is similar to the mRNA shots given for covid. (In a related development, Big Pharma is promoting this nasal spray as a treatment for the Chinese Virus.

According to Javara, every year throughout the United States, there are about 177,000 adults aged 65 and older who are hospitalized due to RSV. Around 14,000 of them wind up passing away, and the care for the remaining patients costs approximately $3 billion each year.

If you can, PLEASE donate so that we can keep sharing important news with you… You can support our efforts by buying us a coffee (or tea) by donating a few dollars. https://gogetfunding.com/realnewscast/

Respiratory syncytial virus

“RSV represents an often unrecognized but still very genuine and imminent danger to our older population,” says Michael Clay, Javara’s Chief Operation Officer. “When it comes to causing serious respiratory disease in adults, RSV is second only to the flu,” says Michael Clay. “The flu is the most common cause.” Having the ability to vaccinate against it would avoid hospitalizations, save lives, and preserve the resources of the healthcare system. Where have we heard this before?

They went on to say “By seizing this opportunity to try a promising preventative RSV vaccination, older folks are raising the likelihood that they may be protected against the discomforts and hazards of this virus,” said the study’s author.

In the meantime, the people who take part in these clinical trials are going to do their part to alleviate suffering and save lives all around the world by contributing to the furtherance of this study.

Be wary of the onslaught of brand-new mRNA medication items that are about to enter the marketplace.

There is now neither an approved therapy nor a vaccination available for the respiratory syncytial virus (RSV), as stated by the industry that deals with death care.

However, there are many treatments that have not been approved by the FDA. Avoid getting vaccinated because it has been demonstrated that these types of vaccines can weaken the immune system.

The mRNA technology that is used in Moderna’s Fauci Flu vaccinations, which have been connected to pericarditis and a plethora of other fatal illnesses, is said to be present in the company’s latest candidate for an RSV vaccine, according to Moderna.

According to Moderna, the clinical studies that have been carried out thus far on the RSV injection “showed encouraging results.” After all, when has a pharmaceutical corporation ever admitted that its products are not “safe and effective?”

The next round of studies, which is currently being put together, will look at the way the mRNA injection for RSV affects people in their later years with a greater degree of specificity.

In addition, Moderna revealed that it intends to introduce multi-valent combo influenza, covid, and RSV injection using mRNA technology. The company said that this injection has the potential to alter the “immunizations landscape.”

As per Francesca Ceddia, who serves as chief executive officer of pulmonary vaccinations at Moderna, the development of combination medicine is only getting started. The company anticipates beginning the initial round of clinical tests by year’s end.

In an interview, Ceddia made the statement that “we have noticed in preclinical studies a very significant immune reaction against all of the antigens.” “This is yet another essential characteristic of mRNA vaccines, in particular the mRNA platform, which makes it possible to include an increasing number of antigens in combination.”

Ceddia continued by saying that in the not-too-distant future, you will be able to walk into a pharmacy and receive a single injection that includes all of Moderna’s mRNA medications, this will be of particular interest to parents of younger children because it will free them from the obligation of bringing their children back on a predetermined schedule for a variety of vaccinations.

I receive no financial support from the Gates Foundation or any other organization or government. If you can spare a few cents to help us keep going, It will be greatly appreciated. https://rb.gy/t1gbv8

We would be grateful if you could donate a few $$ to help us keep operating https://gogetfunding.com/realnewscast/

Share This Post With A Friend!